1. Extraordinary Cases of VTE Prevention in Patients With Cancer

2. Patient Case

3. Risks of Cancer-Associated PE

4. CLOT A Landmark Study for Treatment of Cancer-Associated Thrombosis

5. Hokusai-VTE Cancer Study Design

6. Hokusai VTE-Cancer Primary Endpoint

7. Risk of Recurrent VTE in Cancer

8. SELECT-D Study Design

9. SELECT-D Efficacy and Safety

10. Dose Reduction in NOAC Trials

11. Clinical Implications of Hokusai VTE-Cancer and SELECT-D

12. Sites of Major Bleeding

13. Use of NOACs in Cancer-Associated VTE Considerations for GI Tract

14. US Prescription Patterns for Cancer-Associated VTE

15. Cost Considerations for VTE prevention

16. Anticoagulation and Cancer Recurrence Implications for Surgical interventions

17. Abbreviations